Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action
- 31 January 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (1), 99-104
- https://doi.org/10.1016/s0960-894x(00)80100-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.Stroke, 1992
- The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the ratBrain Research, 1992
- Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampusNeuroscience Letters, 1991
- The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsyEuropean Journal of Pharmacology, 1991
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneuronesNeuroscience Letters, 1991
- Excitatory amino acid neurotoxicity and neurodegenerative diseaseTrends in Pharmacological Sciences, 1990
- Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466European Journal of Pharmacology, 1989
- Effects of new non‐N‐methyl‐D‐aspartate antagonists on synaptic transmission in the in vitro rat hippocampus.The Journal of Physiology, 1989
- Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the hippocampus in vitroNeuroscience Letters, 1988